| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/01/2011 | US20110212084 Binding members for ige molecules |
| 09/01/2011 | US20110212083 Role of soluble upar in the pathogenesis of proteinuric kidney disease |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110212029 Detection of cancer |
| 09/01/2011 | US20110212022 Antitumor antibodies, proteins, and uses thereof |
| 09/01/2011 | CA2791025A1 Method of inducing the production of protective anti-hiv-1 antibodies |
| 09/01/2011 | CA2790978A1 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 09/01/2011 | CA2790866A1 Anti-alpha2 integrin antibodies and their uses |
| 09/01/2011 | CA2790412A1 Folate receptor 1 antibodies and immunoconjugates and uses thereof |
| 09/01/2011 | CA2790014A1 Fully human anti-vegf monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | CA2790013A1 Fully human anti-tnf-.alpha. monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | CA2790007A1 Fully human anti- her2 monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | CA2789963A1 Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies |
| 09/01/2011 | CA2789132A1 Antagonist il-7 receptor antibodies to treat type 2 diabetes and immunological disorders |
| 09/01/2011 | CA2788992A1 Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris |
| 09/01/2011 | CA2787952A1 Anti-angiogenesis therapy for the treatment of ovarian cancer |
| 09/01/2011 | CA2787657A1 Compositions and methods for the diagnosis and treatment of tumor |
| 08/31/2011 | EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions |
| 08/31/2011 | EP2361988A1 Molecular marker for cancer stem cell |
| 08/31/2011 | EP2361982A1 Human gene encoding ubiquitin conjugating enzyme |
| 08/31/2011 | EP2361978A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 08/31/2011 | EP2361936A1 Antigen-binding molecule and uses thereof |
| 08/31/2011 | EP2361935A1 Anti-CD28 humanized antibodies |
| 08/31/2011 | EP2361934A2 Hepatocyte growth factor (HGF) binding proteins |
| 08/31/2011 | EP2361933A2 Antibodies against interleukin-1 beta |
| 08/31/2011 | EP2361932A1 Immunoglobulin chimeric monomer-dimer hybrids |
| 08/31/2011 | EP2361931A1 Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
| 08/31/2011 | EP2361929A1 Neoplasm-specific polypeptides and their use |
| 08/31/2011 | EP2361638A1 A beta 1-42 specific monoclonal antibodies with therapeutic properties |
| 08/31/2011 | EP2361636A1 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361633A1 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 08/31/2011 | EP2361263A1 Use of anti-cs1 antibodies for treatment of rare lymphomas |
| 08/31/2011 | EP2361096A1 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever |
| 08/31/2011 | EP2361095A1 Antagonists of il-6 to raise albumin and/or lower crp |
| 08/31/2011 | EP2054431B1 Conformers of bacterial adhesins |
| 08/31/2011 | EP1682582B1 Method for the mass production of immunoglobulin constant region |
| 08/31/2011 | EP1625163B1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-43 |
| 08/31/2011 | EP1401498B1 Anti-ngf antibodies for the treatment of various disorders |
| 08/31/2011 | EP1095140B1 Neurotrophic factors |
| 08/31/2011 | CN102171248A Cross-species-specific PSMAxCD3 bispecific single chain antibody |
| 08/31/2011 | CN102171247A TNF-alpha antagonist multi-target binding proteins |
| 08/31/2011 | CN102171241A Epitopes derived from SATB2 and uses thereof |
| 08/31/2011 | CN102171237A Methods for purifying antibodies using protein a affinity chromatography |
| 08/31/2011 | CN102170909A Anti-NOTCH2 antibodies and methods of use |
| 08/31/2011 | CN102170907A Pharmaceutical composition for treatment and prevention of cancer |
| 08/31/2011 | CN102170906A Compositions and methods for antibodies targeting complement protein C5 |
| 08/31/2011 | CN102170905A Therapeutic agent or preventive agent for osteoarthritis |
| 08/31/2011 | CN102168100A Echinococcus granulosusglutathione transferase gene and application thereof |
| 08/31/2011 | CN102168089A Echinococcus granulosus calreticulin gene and application thereof |
| 08/31/2011 | CN102168076A An ubiquitin ligase and the application thereof |
| 08/31/2011 | CN102168072A A monoclonal antibody of anti-clenobuterol hydrochloride and a kit for detecting clenobuterol hydrochloride |
| 08/31/2011 | CN102168071A Anti-melamine monoclonal antibody and kit for detecting melamine |
| 08/31/2011 | CN102167746A SPG-(Streptococcal Protein G) antibody polymer and preparation method as well as application thereof |
| 08/31/2011 | CN102167745A Human monoclonal antibody against IgE, preparation method and purpose thereof |
| 08/31/2011 | CN102167744A Human anti-CD20 monoclonal antibody and preparation method and application thereof |
| 08/31/2011 | CN102167743A Human monoclonal antibody against EGFR, preparation method and purpose thereof |
| 08/31/2011 | CN102167742A Human monoclonal antibody against HER2, preparation method and purpose thereof |
| 08/31/2011 | CN102167741A Fully human anti-TNF-alpha (Tumor Necrosis Factor-alpha) monoclonal antibody and preparation method as well as application thereof |
| 08/31/2011 | CN102167740A Fully human anti-VEGF (Vascular Endothelial Growth Factor) monoclonal antibody and preparation method as well as application thereof |
| 08/31/2011 | CN101348777B Influenza A virus ELISA nucleoprotein capture antigen diagnose reagent kit and special monoclonal antibody therefor |
| 08/30/2011 | US8008453 immunoglobulin domain peptides having myostatin, erythropoietin or thrombopoietin peptides as an internal sequence, preferably in a loop region of the domain; antibodies |
| 08/30/2011 | US8008452 Phosphorylated Ndr kinase |
| 08/30/2011 | US8008451 Antibodies to TNF (tumor necrosis factor) receptor family members |
| 08/30/2011 | US8008450 Therapeutic use of anti-CS1 antibodies |
| 08/30/2011 | US8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
| 08/30/2011 | US8008448 Nicotine specific monoclonal antibody for use in treatment cigarette addiction |
| 08/30/2011 | US8008447 Crystallization of antibody or fragment thereof |
| 08/30/2011 | US8008446 Auto-antibodies against the melanocortin-4 receptor |
| 08/30/2011 | US8008443 Modulation of antibody effector function by hinge domain engineering |
| 08/30/2011 | US8008442 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 08/30/2011 | US8008076 Method of producing a nucleic acid encoding an antibody |
| 08/30/2011 | US8008073 Anti-Mpl antibodies |
| 08/30/2011 | US8008027 Methods of screening for compounds that modulate the activity of ADEC, a chemokine expressed in inflamed adenoid |
| 08/30/2011 | US8008025 Biomarkers for neurodegenerative disorders |
| 08/30/2011 | US8008024 Methods, products and treatments for diabetes |
| 08/30/2011 | US8008004 Compositions and methods for the diagnosis and treatment of tumors of glial origin |
| 08/30/2011 | US8007997 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 08/30/2011 | US8007813 CD95-Fc fusion proteins |
| 08/30/2011 | US8007811 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 08/30/2011 | US8007805 Chimeric antigens for breaking host tolerance to foreign antigens |
| 08/30/2011 | US8007804 Complement receptor 2 targeted complement modulators |
| 08/30/2011 | US8007803 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 08/30/2011 | US8007802 Antibodies to Lawsonia intracellularis |
| 08/30/2011 | US8007801 Antibodies to Lawsonia intracellularis |
| 08/30/2011 | US8007800 Methods for treating bone cancer pain by administering a nerve growth factor antagonist antibody |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | US8007795 Anti-tissue factor antibodies and methods of use thereof |
| 08/30/2011 | US8007794 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 08/30/2011 | US8007793 Stabilized liquid anti-RSV antibody formulations |
| 08/30/2011 | US8007792 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 08/30/2011 | US8007790 Using modulator of tumor necrosis factor (TNF) pathway such as infliximab, simvastatin; drug screening |
| 08/30/2011 | CA2442577C Cell separation compositions and methods |
| 08/30/2011 | CA2331329C Diacylglycerol acyl transferase proteins |
| 08/30/2011 | CA2288962C Human monoclonal antibodies to epidermal growth factor receptor |
| 08/30/2011 | CA2277561C Intracellular selection |
| 08/30/2011 | CA2190473C Recombinant papilloma virus l1 |
| 08/30/2011 | CA2174429C Transgenic animals harboring app allele having swedish mutation |